x
Visit our new Mobile Website next time you access NetDania with your mobile device

Repros Therapeutics Inc.

0.47
18-19:59:58 GMT
+0
+0.45%
ISIN:US76028H2094

Figures - Repros Therapeutics Inc.

Open
0.48
Close
0.46
Year Change
-64.61
Year % Change
-64.61%
52 Week High
2.15
52 Week Low
0.26
Volume
1201682
Inc. Vol
200

News - Repros Therapeutics Inc.

19-07:22 GMT
Financial News: LSE’s Xavier Rolet to step down as CEO
Source: MarketWatch, Symbol: Repros Therapeutics Inc.
19-07:05 GMT
How To Compete With Amazon This Holiday Season
Source: Forbes World, Symbol: Repros Therapeutics Inc.
19-07:01 GMT
19-06:54 GMT
UK banks 'exposed to money laundering in South Africa'
Source: BBCBusiness, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
Big Blue Brings Big Milestone
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
4 Big Winners Yielding Over 10 Percent
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
ZTE Shares Tumble on 3Q Results, Buy on Dip?
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
How Does Chipotle Escape Its Queso Quagmire?
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
3 Stocks to Buy and Forget About
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
6 Key Metrics From Netflix Inc.'s Earnings Report
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
Why Does Amazon Want to Scan My Body?
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
Skittish Lenders May Have Just Killed Nordstrom's Go-Private Deal
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
A Detour Into Upgrades and Downgrades
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
Why Is Toyota Doubling Down on Hydrogen Fuel Cells?
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
Two Keys to Sales Growth for This High-Flying Beverage Giant
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
Honda Sharpens Its All-New 2018 Accord to Steal SUV Sales
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
What Does Ford's $267 Million Recall Mean for Investors?
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
3 High-Yield Renewable Energy Stocks
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:47 GMT
Japan September Exports Jump 14.1%
Source: NASDAQ Stocks, Symbol: Repros Therapeutics Inc.
19-06:34 GMT
Foster & Dunhill Saga Ends With Convictions And Donaldson Claiming To Be Too Fat To Jail
Source: Forbes Personal Finance, Symbol: Repros Therapeutics Inc.
19-06:16 GMT
Futures Movers: WTI crude, Brent prices hover at highest levels in weeks
Source: MarketWatch, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Positive Start to the Q3 Earnings Season
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
19-06:05 GMT
Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,624.22.
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Health Care Sector Update for 10/18/2017: VKTX,SPPI,AKTX
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
How to Buy a Car With Your Partner
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
6 Key Metrics From Netflix Inc.'s Earnings Report
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
What Can We Expect From Textron's Q3 Earnings
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Schlumberger's 3Q'17 Earnings To Surge Backed By Continued US Drilling Demand
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
How Does Chipotle Escape Its Queso Quagmire?
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
eBay's Margins Could Remain Under Pressure Even As StubHub Sales Pick Up
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Growth In Interest Earning Assets, Trading Volumes Should Boost E-Trade's Q3
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Johnson & Johnson Posts Solid Q3 Numbers Led By Ramp Up In Oncology Drugs
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
A Detour Into Upgrades and Downgrades
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Does Avon Stand A Chance For Recovery?
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
IBM Earnings: Revenues Stabilize As Strategic Imperatives Gain Traction
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Big Blue Brings Big Milestone
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
4 Big Winners Yielding Over 10 Percent
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
ZTE Shares Tumble on 3Q Results, Buy on Dip?
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Daimler AG Q3 2017 Earnings Preview
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Here's Why TripAdvisor Is Strengthening Its Tours And Activities Segment
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Honda Sharpens Its All-New 2018 Accord to Steal SUV Sales
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
What Does Ford's $267 Million Recall Mean for Investors?
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
3 High-Yield Renewable Energy Stocks
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Two Keys to Sales Growth for This High-Flying Beverage Giant
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Japan September Exports Jump 14.1%
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
What Are Treasuries And The Dollar Telling Us About Stocks?
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Why Does Amazon Want to Scan My Body?
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Health Care Sector Update for 10/18/2017: SSKN,SPPI,AKTX
Source: NASDAQ US Markets, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Why Is Toyota Doubling Down on Hydrogen Fuel Cells?
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-06:05 GMT
Skittish Lenders May Have Just Killed Nordstrom's Go-Private Deal
Source: NASDAQ International, Symbol: Repros Therapeutics Inc.
19-05:43 GMT
19-05:43 GMT
Today's Google Doodle Honors Astrophysicist Subrahmanyan Chandrasekhar
Source: Forbes World, Symbol: Repros Therapeutics Inc.
19-05:00 GMT
US: Tillerson calls for India ties to counter China
Source: BBC US-Canada, Symbol: Repros Therapeutics Inc.
19-04:31 GMT
Why Space Data Is The New Big Data
Source: Forbes World, Symbol: Repros Therapeutics Inc.
19-04:27 GMT
1 in 5 white women who use indoor tanning are addicted to it
Source: MarketWatch, Symbol: Repros Therapeutics Inc.
19-04:10 GMT
What China's Belt And Road Initiative Is Really All About
Source: Forbes World, Symbol: Repros Therapeutics Inc.
19-04:04 GMT
Is the most hated bull market in stocks becoming dangerously over-loved?
Source: MarketWatch, Symbol: Repros Therapeutics Inc.
19-04:04 GMT
This six-figure tech job had the biggest bump in salary over 10 years
Source: MarketWatch, Symbol: Repros Therapeutics Inc.
19-04:04 GMT
More than half of LGBT workers face repeated bullying
Source: MarketWatch, Symbol: Repros Therapeutics Inc.
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Top Brokers
Global
Forex
23134.70
-38.3
-0.17%
2557.88
-4.2
-0.16%
6105.40
-10.5
-0.17%
5561.70
-23.9
-0.43%
13036.15
-20.8
-0.16%
21440.50
-5
-0.02%
3370.17
-11.62
-0.34%
7520.30
-20.5
-0.27%
28260.00
-410
-1.43%
5885.00
-2
-0.03%
10210.85
-23.6
-0.23%
1281.28
0.98
0.08%
58.02
-0.155
-0.27%
1.18133
0.0019
0.16%
112.944
-0.068
-0.06%
1.31948
-0.0016
-0.12%
0.78655
0.0023
0.30%
1.24648
-0.0001
-0.01%
133.42900
0.141
0.11%
0.89525
0.0026
0.29%
149.04000
-0.262
-0.18%
0.98014
-0.001
-0.10%
1.15783
0.0006
0.06%
0.70456
-0.0109
-1.53%
93.31400
-0.109
-0.12%
Top Gainers
Name
Last
+/-
%
1.98
0.80
68.51%
2.00
0.56
38.89%
28.90
6.44
28.67%
37.65
8.13
27.54%
1.24
0.26
26.57%
2.60
0.53
25.60%
2.18
0.38
21.11%
0.37
0.06
20.33%
0.11
0.02
18.32%
17.76
2.65
17.54%
Top Losers
Name
Last
+/-
%
4.50
-1.90
-29.69%
0.36
-0.13
-26.53%
3.65
-1.25
-25.49%
1.33
-0.39
-22.67%
2.10
-0.60
-22.22%
6.55
-1.65
-20.12%
7.01
-1.76
-20.07%
0.04
-0.01
-20.00%
9.47
-2.20
-18.85%
0.02
0.00
-18.57%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2017 NetDania Creations ApS, Kronprinsessegade 36, 1st floor DK-1306 Copenhagen K, Denmark, +4536980409, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy